Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / China

Eisai Announces New Asian Expansion Plans

September 2006 | Company Finance Alert

Japan's fourth-ranked drugmaker, Eisai Co, has announced more details of plans to expand in Asia. Aside from heavy investment in manufacturing in the US, the firm has also announced a JPY5bn (US$46mn) production and R&D plant in India, and recently confirmed Singapore as its major base in Asia outside of

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.

Related Insight Articles
Dishman To Build Chinese API Plant

Industry / China In an effort to further penetrate the rapidly expanding contract research and manufacturing services (CRAMS) market, Indian firm Dishman Pharmaceuticals and Chemicals is to build an active pharmaceutical...
January 2008
Bayer To Purchase Local OTC Player

Companies / China German drug giant Bayer has announced that it is to purchase the OTC division of Chinese drugmaker Topsun Group for EUR103mn (US$130.55mn), with another EUR19mn (US$24.08mn) earmarked for success-related...
October 2006
Asian API Manufacturers Pressure European Peers

Companies / China European Active Pharmaceutical Ingredient (API) manufacturers are facing a strong challenge from low cost producers in Asia, which are undercutting prices for bulk pharmaceuticals and other basic chemicals....
August 2006
Asia Struggles With HIV/AIDS Epidemic

Companies / China Asia is struggling to cope with its emerging HIV/AIDS epidemic due to limited access to life-saving ARV treatments, claim industry observers. In countries such as Vietnam, India, and Bangladesh, the...
June 2006
Multinationals Eye Chinese, Indian Research Potential

Companies / China Multinational drugmakers should undertake more R&D in India and China as a way of cutting costs, claims a new study by US-based consultancy Boston Consulting Group (BCG). According to BCG, the overall...
May 2006


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2009 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS